{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-033558","form_type":"8-K","ticker":"EUDA","cik":"0001847846","company_name":"EUDA Health Holdings Ltd","filed_at":"2022-11-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:52.707960+00:00","generated_at":"2026-06-21T13:37:37.030192+00:00","sec_items":["1.01","2.01","5.06","9.01","4.01","3.01","3.03","5.01","5.02","5.03","5.05","8.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"EUDA Health completes business combination with 8i Acquisition 2 Corp.; now public on Nasdaq","bullets":["Business combination closed Nov 17, 2022; 8i Acquisition 2 renamed EUDA Health Holdings Limited.","Ordinary shares and warrants trade on Nasdaq under EUDA and EUDAW; prior symbols LAX, LAXXW, etc. delisted.","Watermark Developments holds 38.5% of 22.4M outstanding shares; Meng Dong (James) Tan holds 23.4%.","Lock-up agreement: Seller and designees cannot dispose of Lockup Shares for 18 months post-closing.","Auditor changed from UHY to Marcum Asia CPAs LLP effective after closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-033558","json":"https://secwatch.observer/filing/0001493152-22-033558.json","markdown":"https://secwatch.observer/filing/0001493152-22-033558.md","text":"https://secwatch.observer/filing/0001493152-22-033558.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T13:37:37.030192+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"23e3cde303eba38e58350e1b7fe3290da6595659","claim":"EUDA Health Holdings Ltd: Company ceased to be a shell company as of the Closing.","evidence_excerpt":"the Company ceased to be a shell company (as defined in Rule 12b-2 of the Exchange Act) as of the Closing.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"shell status"}],"fact_type":"governance_change"},{"claim_id":"2c59b1b6b6b665a1d364a4f9fae929d61fe7b388","claim":"EUDA Health Holdings Ltd: Changed the fiscal year to end on December 31.","evidence_excerpt":"Following the Closing, the Company changed its fiscal year to end on December 31.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"fiscal year change"}],"fact_type":"governance_change"},{"claim_id":"7396ed411e0a68debe8b5343d3e8f1139c7478f8","claim":"EUDA Health Holdings Ltd: Board adopted a new Code of Business Conduct and Ethics (effective 2022-11-17).","evidence_excerpt":"on November 17, 2022, the Board considered and adopted a new Code of Business Conduct and Ethics (the “Code of Ethics”).","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"code of ethics"},{"label":"Effective","value":"2022-11-17"}],"fact_type":"governance_change"},{"claim_id":"b6c4affdefdf438a264a97372e2de0dbe64530f3","claim":"EUDA Health Holdings Ltd: Adopted Amended and Restated Memorandum and Articles of Association, effective as of the Closing Date.","evidence_excerpt":"8i Acquisition 2 Corp. changed its name to EUDA Health Holdings Limited and adopted the Amended and Restated Memorandum and Articles of Association, effective as of the Closing Date.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","confidence":0.95,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"}],"fact_type":"governance_change"},{"claim_id":"4ceca71a164a338bfabd10e84ea21c62d382a00e","claim":"EUDA Health Holdings Ltd completed an acquisition involving Watermark Developments Limited (closed 2022-11-17).","evidence_excerpt":"On November 17, 2022 (the \"Closing Date\" ), EUDA Health Holdings Limited, a British Virgin Islands business company (formerly known as 8i Acquisition 2 Corp.) (the \"Company\" ), consummated the previously announced business combination contemplated by the Share Purchase Agreement (the \"SPA\" ) between 8i Acquisition 2 Corp., a BVI business company ( \"8i\" ), EUDA Health Limited, a British Virgin Islands business company ( \"EUDA\" ), Watermark Developments Limited, a British Virgin Islands business company ( \"Watermark\" or the \"Seller\" ), and Kwong Yeow Liew, dated April 11, 2022 and amended May 30, 2022, June 10, 2022, and September 7, 2022.","evidence_source":"SEC 8-K Item 2.01/5.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","confidence":0.9,"family_label":"M&A Transactions","details":[{"label":"Action","value":"acquisition"},{"label":"Counterparty","value":"Watermark Developments Limited"},{"label":"Closing","value":"2022-11-17"}],"fact_type":"ma_transaction"},{"claim_id":"04cf31d69c92704226eed587c02c88d4ee999d25","claim":"EUDA Health Holdings Ltd entered into Lock-up Agreements with the Seller and its designees.","evidence_excerpt":"the Seller and its designees entered into lock-up agreements agreeing, subject to certain exceptions, not to (i) offer, sell contract to sell, pledge or otherwise dispose of, directly or indirectly, any Lockup Shares","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","confidence":0.7,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"the Seller and its designees"}],"fact_type":"material_agreement"},{"claim_id":"b235a6277fa51c2567ab0ae3c8a5c0066fbdbb28","claim":"EUDA Health Holdings Ltd entered into Seller Release with Seller.","evidence_excerpt":"ith certain existing stockholders of the Company and with the Seller with respect to their shares of the Company acquired before or pursuant to the Share Purchase, and including the shares issuable on conversion of the warrants issued to the Sponsor in connection with","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","confidence":0.7,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"settlement"},{"label":"Counterparty","value":"Seller"}],"fact_type":"material_agreement"},{"claim_id":"e0d6d12270e130ff368c7a0a6fd1e2bd92fe6727","claim":"EUDA Health Holdings Ltd amended Amended and Restated Registration Rights Agreement with certain existing stockholders of the Company and with the Seller.","evidence_excerpt":"the Company entered into an amended and restated registration rights agreement (as amended, the “Amended and Restated Registration Rights Agreement”)","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1847846/000149315222033558/0001493152-22-033558-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"certain existing stockholders of the Company and with the Seller"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}